Viking Global Equities Master Ltd.'s Net Worth
$1.51 Billion
Who is Viking Global Equities Master Ltd.?
Viking Global Equities Master Ltd. has an estimated net worth of $1.51 Billion. This is based on reported shares across multiple companies, which include Urovant Sciences Ltd., Adaptive Biotechnologies Corp, Arbutus Biopharma Corp, Myovant Sciences Ltd., Roivant Sciences Ltd., Axovant Gene Therapies Ltd., APi Group Corp, and BridgeBio Pharma, Inc..
SEC CIK
Viking Global Equities Master Ltd.'s CIK is 0001759530
Past Insider Trading and Trends
2019 was Viking Global Equities Master Ltd.'s most active year for acquiring shares with 36 total transactions. Viking Global Equities Master Ltd.'s most active month to acquire stocks was the month of May. 2019 was Viking Global Equities Master Ltd.'s most active year for disposing of shares, totalling 6 transactions. Viking Global Equities Master Ltd.'s most active month to dispose stocks was the month of May. 2022 saw Viking Global Equities Master Ltd. paying a total of $200,000,000.00 for 200,000 shares, this is the most they've acquired in one year. In 2020 Viking Global Equities Master Ltd. cashed out on 8,412,899 shares for a total of $302,143,539.29, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adaptive Biotechnologies Corp (ADPT) Snapshot price: $3.83
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.23% | -1.00M |
$55.65 | -$55,650,000.00 | 29.99M |
Dec 14
| |||
Form 4
| -7.46% | -2.50M |
$49.52 | -$123,787,500.00 | 30.99M |
Nov 11
| |||
Form 4
| -12.79% | -4.91M |
$24.98 | -$122,706,039.29 | 33.49M |
Jan 28
| |||
Form 4
| +2,595.20% | 36.98M |
$20.00 |
—
| 38.41M |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
APi Group Corp (APG) Snapshot price: $34.16
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.95M |
$38.15 | -$74,460,483.30 |
0
|
Jun 17
| |||
Form 4
| -60.89% | -3.04M |
$34.25 | -$104,072,632.25 | 1.95M |
Mar 5
| |||
Form 4
| +41.73% | 4.14M |
$30.75 | $51,741,659.70 | 14.05M |
Feb 28
| |||
Form 4
| -18.90% | -6.50M |
$31.30 | -$203,450,000.00 | 27.89M |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
| No matching records found | |||||||||
Roivant Sciences Ltd. (ROIV) Snapshot price: $10.395
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -14.73% | -13.00M |
$9.90 | -$128,700,000.00 | 75.24M |
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Urovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +0.08% | 18.2K |
$8.32 | $151,380.99 | 22.86M |
Scheduled
|
Jun 17 - Jun 19
| ||
Form 4
| +0.10% | 22.01K |
$8.06 | $177,300.64 | 22.84M |
Scheduled
|
Jun 12 - Jun 14
| ||
Form 4
| +0.09% | 21.34K |
$8.31 | $177,247.38 | 22.82M |
Scheduled
|
Jun 7 - Jun 11
| ||
Form 4
| +0.09% | 21.12K |
$7.86 | $165,950.15 | 22.8M |
Scheduled
|
Jun 4 - Jun 6
| ||
Form 4
| +0.08% | 17.75K |
$7.83 | $138,946.36 | 22.78M |
Scheduled
|
May 30 - Jun 3
| ||
Form 4
| +0.06% | 14.48K |
$7.63 | $110,461.18 | 22.76M |
Scheduled
|
May 24 - May 29
| ||
Form 4
| +0.09% | 19.83K |
$8.22 | $162,918.35 | 22.75M |
Scheduled
|
May 21 - May 23
| ||
Form 4
| +0.07% | 21.61K |
$7.63 | $162,884.29 | 31.35M |
May 16 - May 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Myovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +6.32% | 2.42M |
$8.25 | $19,999,996.50 | 40.77M |
Jun 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||